Clinical Trial Update: Stromal Vascular Fraction for Treatment of Xerostomia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating stromal vascular fraction for xerostomia due to radiotherapy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Xerostomia

Drugs mentioned

• Stromal Vascular Fraction (stromal vascular fraction)

Snippet

Sponsor: Midwestern Regional Medical Center | Conditions: Xerostomia Due to Radiotherapy (Disorder) | Phase 1, Phase 2 | Status: WITHDRAWN